Rie Horii
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 19, 2023
Intratumoral heterogeneity, treatment response, and survival outcome of ER-positive HER2-positive breast cancer.Natsuki Teruya, Hiroaki Inoue, Rie Horii
|Jan 26, 2021
Predictive significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, for resistance to trastuzumab-based treatments for HER2-positive breast cancer.Rie Horii, Hiroaki Nitta, Masanori Nojima
|May 23, 2020
Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.Rie Horii, Hitoshi Tsuda, Shinobu Masuda
|Nov 30, 2017
Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.Hiroaki Inoue, Rie Horii, Yoshinori Ito
Pageof 1
